Loading...

BHC BAUSCH HEALTH COMPANIES INC Investments/Divestments 8-K Filing

BSCH

BHC

BAUSCH HEALTH COMPANIES INC

(BHC)

2023 8-K

Show Summary

Summary

Debt Restructuring

Debt Restructuring

Financial Statements

Shareholder Rights Plan

Financial Results

Q3 Earnings Report

Financial Results Announcement

Appointment of CFO

Annual Meeting of Shareholders

Financial Results Announcement

Financial Results Announcement

Departure of Directors

Acquisition of XIIDRA and o...

Financial Results Announcement

Secured Notes Offering

Resignation of CFO

Acquisition Financing

Acquisition of XIIDRA and o...

Financial Results Announcement

Acquisition of XIIDRA and o...

Annual Meeting of Shareholders

Financial Results Announcement

External Links:

Bausch + Lomb, a subsidiary of Bausch Health Companies Inc., completed a $1.4 billion secured notes offering to fund the acquisition of XIIDRA and other ophthalmology assets from Novartis.

AI Assistant

BAUSCH HEALTH COMPANIES INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.